Blouin News Blogs
<img alt="" height="1" width="1" />
UPDATE 1-Data supports fast approval for Roche's breast cancer drug -FDA staff
Reuters
Tue Sep 10, 2013 7:11pm IST. Sept 10 (Reuters) - Trial data on Swiss drugmaker Roche's breast cancer treatment Perjeta supported a faster approval of the drug for use in early stages of the disease, reviewers for the U.S. Food and Drug Administration said ...
FDA reviewers back Roche's Perjeta in early breast cancerFiercePharma
Roche's Perjeta Works as Early Option for Breast CancerBloomberg
FDA: Roche drug works in early-stage breast cancerBusinessweek
Bustle -WREX-TV
all 22 news articles »
More...